Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Preferred Shares Issued (2020 - 2021)

Historic Preferred Shares Issued for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q1 2021 value amounting to $6.3 million.

  • Rani Therapeutics Holdings' Preferred Shares Issued changed N/A to $6.3 million in Q1 2021 from the same period last year, while for Dec 2021 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $6.3 million for FY2021, which is 9077.25% down from last year.
  • According to the latest figures from Q1 2021, Rani Therapeutics Holdings' Preferred Shares Issued is $6.3 million.
  • Rani Therapeutics Holdings' Preferred Shares Issued's 5-year high stood at $68.5 million during Q4 2020, with a 5-year trough of $6.3 million in Q1 2021.